Welltower Inc. · WELL · FY2026 Q1 · Calendar Q2 2026

Welltower Q1 2026: Revenue Surges 38%, FFO Guidance Raised Again on Senior Housing Strength

Welltower delivered a strong Q1 2026, with revenue up 38% year-over-year to $3.35 billion and FFO per share up 23%, beating consensus on both lines. The company raised full-year FFO guidance to a $6.28 midpoint, up from $6.17, driven by record 16.4% same-store NOI growth in its senior housing operating portfolio, which now accounts for 74% of same-store NOI. A new development is the first external licensing of Welltower's proprietary data-science platform, creating a capital-light revenue stream. Despite the beat, the stock's abnormal return was roughly -1% on the report, suggesting the market had largely priced in the strong trajectory. The investment thesis centers on continued senior-housing occupancy gains, aggressive capital deployment, and the emerging platform monetization opportunity.

Reported After market closeNYSEReal Estate $175.63B market cap
100quality score

Company context

Snapshot as of publication

Welltower Inc. (NYSE:WELL), an S&P 500 company based in Toledo, Ohio, is a leader in reshaping healthcare infrastructure. This Real Estate Investment Trust (REIT) strategically collaborates with premier operators in seniors housing, post-acute care, and health systems. Their core mission is to finance the vital property assets required to expand innovative care delivery models, thereby enhancing overall public wellness and healthcare experiences. Welltower's portfolio encompasses a variety of properties, including seniors housing, post-acute communities, and outpatient medical facilities, all situated primarily within key, rapidly growing markets across the United States, Canada, and the United Kingdom.

Earnings scorecard

Reported versus consensus
Reported EPS $1.02 Consensus $1
EPS surprise +50.2% Reported versus consensus
Reported revenue $3.35B Consensus $3.18B
Revenue surprise +5.5% Reported versus consensus

Market reaction

event-close to next-session close
Stock move -1.0% Event window
SPY move -0.0% Same window
Abnormal move -1.0% Stock minus SPY
Volume 1.4× Versus trailing sessions
Subsequent drift -0.8% Up to 20 sessions
WELLSPY benchmark

Follow WELL with an agent that reads every filing, transcript, and price print. Free to start.

Try FN2 free

Transcript intelligence

What changed

Q1 2026 revenue of $3.35B beat the $3.18B estimate by 5.5%, while EPS of $1.02 exceeded the $0.68 estimate by 50.2%. Full-year FFO guidance midpoint was raised from $6.17 to $6.28 per share. Same-store NOI grew a record 16.4%, with 20% growth in communities at 95%+ occupancy. The company closed $3.2B in acquisitions during the quarter with a $7.3B pipeline remaining. Balance sheet strengthened: net debt/EBITDA fell to 2.73x, cash stood at $4.9B, and a $700M unsecured bond was paid off. Notably, the data-science platform generated its first external licensing revenue through agreements with Public Storage and a global private-equity firm. The stock moved approximately -1% on the report, with volume 1.41x the baseline and subsequent drift of -0.85%.

Guidance delta

Full-year 2026 normalized FFO guidance midpoint raised from $6.17 to $6.28 per share, an increase of $0.11. Same-store NOI growth target set at 12.25% to 16% across all sub-segments. CapEx outlook is stable. Management tone remains confident, and guidance sentiment is raised for the second consecutive quarter.

Key takeaways

  • Q1 revenue rose 38% YoY to $3.35B and FFO per share grew 23%, beating EPS estimates by 50% and revenue estimates by 5.5%.
  • Full-year 2026 FFO guidance raised to $6.28 midpoint from $6.17, continuing the upward revision trend.
  • Senior housing operating assets now deliver 74% of same-store NOI, with record 16.4% same-store NOI growth.
  • Data-science platform monetized externally for the first time through licensing deals with Public Storage and a global PE firm.
  • Balance sheet strengthened: net debt/EBITDA at 2.73x, $4.9B cash, $700M unsecured bond paid off.
  • $3.2B deployed in Q1 with $7.3B pipeline; $11B in dispositions completed since early 2025.

Management priorities

  • Continue increasing concentration in senior-housing operating assets as part of the Welltower 3.0 mix shift.
  • Scale the data-science platform through additional external licensing agreements.
  • Complete remaining $500M of outpatient medical sales and pursue further off-market acquisitions including Amica Senior Lifestyles.
  • Maintain digital transformation via the Welltower Business System to improve resident and employee experience.
  • Target full-year same-store NOI growth of 12.25% to 16% across all sub-segments.

Sources

  1. Earnings call transcript and parsed analysis · 2026-05-11T10:29:34.698584+00:00
  2. FN2 earnings calendar · 2026-07-26T00:37:12.209961+00:00
  3. Polygon adjusted daily market bars · 2026-07-28T15:40:58.944826+00:00
  4. Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-07-28T15:40:58.942164+00:00

Methodology

Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.

Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.

By FN2 Research · Updated . For educational purposes only; not investment advice.